Business
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
FOSTER CITY, Calif., January 27, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2025 financial results and guidance will be released on Tuesday, February 10, 2026 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2025 financial results and provide a business update.
About this update from Gilead Sciences, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1728,"height":576,"url":"https://media.zenfs.com/en/business-wire.com/c15e39a3f49948a51cfacae0f6235b52"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/qwGrEXMCWph0J1E6dewuyw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c15e39a3f49948a51cfacae0f6235b52","width":960,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/aOJLcuO7SxTwMz_Q718c9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/c15e39a3f49948a51cfacae0f6235b52","width":1200,"height":400}},"lazy":false},{"type":"text","content":"FOSTER CITY, Calif., January 27, 2026--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2025 financial results and guidance will be released on Tuesday, February 10, 2026 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2025 financial results and provide a business update.","length":438,"tagName":"p"},{"type":"text","content":"A live webcast will be available in the Investors section of www.gilead.com and will be archived there for one year.","length":116,"tagName":"p"},{"type":"text","content":"About Gilead Sciences","length":21,"tagName":"p"},{"type":"text","content":"Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.","length":457,"tagName":"p"},{"type":"text","content":"For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.","length":204,"tagName":"p","attribs":{}},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20260127158594/en/...